Keyword: Baxter International
Sanofi plans to offload its Seprafilm business to Baxter, setting up an infusion of cash for early next year as it considers new priorities.
With $225 million from TPG Capital and Vida Ventures and $10 million from its founders and board members, AskBio will ramp up clinical trials and manufacturing.
Baxter’s Altapore bone graft substitute was cleared as a supplement to autografts of a patient’s bone in posterolateral spinal fusion surgeries.
Baxter received FDA clearance for a formulation of its Actifuse synthetic bone graft, deliverable via a prepackaged syringe requiring no preparation.
A study of 100 physicians who received payments from device makers declared their conflict of interest in journal articles only 37% of the time.
Here's Friday's medtech news of note.
The takeover will bolster Fresenius’ at-home dialysis unit, positioning it to profit if patients opt against receiving treatment in its care centers.
Baxter launched a new type of hemodialysis in a handful of countries, which uses a new dialyzer that filters a greater range of molecules from the blood, better simulating the function of a natural kidney.
Baxter is teaming up with dialysis care provider Satellite Healthcare to make advanced care available to more patients in the U.S.
Robert Parkinson had a lot on his plate during his last year as Baxter’s CEO in 2015. The med tech helmsman oversaw a spinout of the company’s biopharma business, Baxalta, before former Covidien CEO Jose Almeida took the reins in 2016.